CALA — Calithera Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Calithera Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2018 December 31st	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	136	157	115	59.5	25.5
Net Total Accounts Receivable
Net Total Receivables	2	0.482	1.54	0	—
Prepaid Expenses
Total Current Assets	140	160	119	61.5	26.6
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.46	8.25	6.44	3.03	1.78
Long Term Investments
Other Long Term Assets
Total Assets	143	169	126	64.8	28.7
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	14.9	19.6	18.4	14	7.39
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	16	26.3	23.2	15.7	8.28
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	127	142	102	49.1	20.4
Total Liabilities & Shareholders' Equity	143	169	126	64.8	28.7
Total Common Shares Outstanding
Total Preferred Shares Outstanding